CBPO [China Biologic Products] SC 13G/A: (Original Filing)

[CUSIP No. 16938C106 SCHEDULE 13G Page 12 of 12 Pages Joint Filing Agreement IDG-ACCEL CHINA GROWTH FUND II L.P. its General Partner its General Partner IDG-ACCEL CHINA GROWTH FUND II ASSOCIATES L.P. its General Partner IDG-ACCEL CHINA GROWTH FUND GP II ASSOCIATES LTD. IDG-ACCEL CHINA INVESTORS II L.P. its General Partner] [16938C106 CUSIP No. 2 12 Page 1 NAMES OF REPORTING PERSONS IDG-Accel China Growth Fund II L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION]

CBPO [China Biologic Products] SC 13G/A: CUSIP No. 16938C106 SCHEDULE 13G Page 12 of

[CUSIP No. 16938C106 SCHEDULE 13G Page 12 of 12 Pages Joint Filing Agreement IDG-ACCEL CHINA GROWTH FUND II L.P. its General Partner its General Partner IDG-ACCEL CHINA GROWTH FUND II ASSOCIATES L.P. its General Partner IDG-ACCEL CHINA GROWTH FUND GP II ASSOCIATES LTD. IDG-ACCEL CHINA INVESTORS II L.P. its General Partner] [16938C106 CUSIP No. 2 12 Page 1 NAMES OF REPORTING PERSONS IDG-Accel China Growth Fund II L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION]

SGOC [SGOCO] 6-K: (Original Filing)

[SGOCO Group Receives Non-Compliance Letter from NASDAQ BEIJING, June 4, 2012 -- SGOCO Group, Ltd. (Nasdaq: SGOC), a company focused on building its own brands and retail distribution network in the Chinese flat panel display market, including monitors, TVs, and application specific products, today announced that it received a letter from The Nasdaq Stock Market indicating that as a result] []

CBPO [China Biologic Products] SC 13D/A: (Original Filing)

[EXECUTION COPY SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement (1) WP X WPP X, Purchasers Purchaser (2) IDG Fund IDG Investors Sellers Seller Parties Party Sellers and Purchasers are collectively referred to herein as the “ WHEREAS: 1. Company China Biologic Products, Inc. (the “ 2. Shares The Company is listed on NASDAQ. As of April 23, 2012, a] []

SGOC [SGOCO] 6-K: SGOCO Group Receives Non-Compliance Letter from NASDAQ BEIJING,

[SGOCO Group Receives Non-Compliance Letter from NASDAQ BEIJING, June 4, 2012 -- SGOCO Group, Ltd. (Nasdaq: SGOC), a company focused on building its own brands and retail distribution network in the Chinese flat panel display market, including monitors, TVs, and application specific products, today announced that it received a letter from The Nasdaq Stock Market indicating that as a result] []

CBPO [China Biologic Products] SC 13D/A: EXECUTION COPY SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE

[EXECUTION COPY SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement (1) WP X WPP X, Purchasers Purchaser (2) IDG Fund IDG Investors Sellers Seller Parties Party Sellers and Purchasers are collectively referred to herein as the “ WHEREAS: 1. Company China Biologic Products, Inc. (the “ 2. Shares The Company is listed on NASDAQ. As of April 23, 2012, a] []

THTI [THT Heat Transfer Technology] DEFA14A: (Original Filing)

[SCHEDULE 14A (RULE 14a-101) THT HEAT TRANSFER TECHNOLOGY, INC. ______________________________________________________________ No fee required. Payment of Filing Fee (Check the appropriate box): (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: Fee paid previously with preliminary materials. (1)]

THTI [THT Heat Transfer Technology] DEFA14A: SCHEDULE 14A (RULE 14a-101) THT HEAT TRANSFER TECHNOLOGY,

[SCHEDULE 14A (RULE 14a-101) THT HEAT TRANSFER TECHNOLOGY, INC. ______________________________________________________________ No fee required. Payment of Filing Fee (Check the appropriate box): (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: Fee paid previously with preliminary materials. (1)]

Skip to toolbar